Cargando…

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design

BACKGROUND: Many screening programs for colorectal cancer (CRC) use the fecal immunochemical test (FIT) to triage individuals for colonoscopy. Although these programs reduce CRC incidence and CRC-related mortality, the detection of advanced precursor lesions (advanced adenomas and advanced serrated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wisse, P. H. A., de Klaver, W., van Wifferen, F., Meiqari, L., Bierkens, M., Greuter, M. J. E., Carvalho, B., van Leerdam, M. E., Spaander, M. C. W., Dekker, E., Coupé, V. M. H., de Wit, M., Meijer, G. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743627/ https://www.ncbi.nlm.nih.gov/pubmed/36503495 http://dx.doi.org/10.1186/s12885-022-10372-2

Ejemplares similares

Colorectal cancer risk after removal of polyps in fecal immunochemical test based screening
por: van Toledo, D.E.F.W.M., et al.
Publicado: (2023)

Accuracy of H. pylori fecal antigen test using fecal immunochemical test (FIT)
por: Nieuwenburg, S. A. V., et al.
Publicado: (2021)

Which Fecal Immunochemical Test Should I Choose?
por: Daly, Jeanette M., et al.
Publicado: (2017)

Implementation of an optical diagnosis strategy saves costs and does not impair clinical outcomes of a fecal immunochemical test-based colorectal cancer screening program
por: Vleugels, Jasper L. A., et al.
Publicado: (2017)

Missed colorectal cancers in a fecal immunochemical test-based screening program: Molecular profiling of interval carcinomas
por: van der Vlugt, Manon, et al.
Publicado: (2022)

Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program
por: van de Schootbrugge-Vandermeer, Hilliene J., et al.
Publicado: (2023)

Profiling small RNAs in fecal immunochemical tests: is it possible?
por: Birkeland, Einar, et al.
Publicado: (2023)

A large proportion of fecal immunochemical test-positive participants in colorectal cancer screening is symptomatic
por: de Klerk, Clasine M, et al.
Publicado: (2017)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
por: Kim, Dong Ju, et al.
Publicado: (2018)

Assessment of disease activity by fecal immunochemical test in ulcerative colitis
por: Ryu, Dae Gon, et al.
Publicado: (2016)

Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?
por: Kim, Nam Hee, et al.
Publicado: (2017)

Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing
por: Saito, Hiroshi
Publicado: (1996)

Improving Adenoma Detection Rates: The Role of the Fecal Immunochemical Test
por: Nwankwo, Eugene C, et al.
Publicado: (2021)

The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening
por: Kooyker, Arthur I., et al.
Publicado: (2020)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
por: Goede, S. Lucas, et al.
Publicado: (2017)

Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
por: Kato, Jun, et al.
Publicado: (2016)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
por: Amitay, Efrat L., et al.
Publicado: (2019)

Clinical implications of fecal calprotectin and fecal immunochemical test on mucosal status in patients with ulcerative colitis
por: Ryu, Dae Gon, et al.
Publicado: (2019)

Patients and Providers Are Amenable to Fecal Immunochemical Testing by Digital Rectal Exam
por: Naidu, Harini, et al.
Publicado: (2018)

Predicting the risk for colorectal cancer with personal characteristics and fecal immunochemical test
por: Li, Wen, et al.
Publicado: (2018)

Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial
por: Nielson, Carrie M., et al.
Publicado: (2018)

Fecal Immunochemical Test and Fecal Calprotectin Results Show Different Profiles in Disease Monitoring for Ulcerative Colitis
por: Hiraoka, Sakiko, et al.
Publicado: (2018)

Leveraging Fecal Microbial Markers to Improve the Diagnostic Accuracy of the Fecal Immunochemical Test for Advanced Colorectal Adenoma
por: Zhang, Yuhan, et al.
Publicado: (2021)

Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions
por: Baxter, Nielson T., et al.
Publicado: (2016)

Effectiveness of a mailed fecal immunochemical test outreach: a Medicare Advantage pilot study
por: Issaka, Rachel B., et al.
Publicado: (2020)

Comparison of patient preferences for fecal immunochemical test or colonoscopy using the analytic hierarchy process
por: Xu, Yinghui, et al.
Publicado: (2015)

Positive Fecal Immunochemical Test or Cologuard in the Era of the Novel Coronavirus Disease-2019 Pandemic
por: Young, Patrick E., et al.
Publicado: (2020)

Feasibility of Mass Screening for Colorectal Cancer Using Fecal Immunochemical Test in Iran
por: Kamangar, Farin, et al.
Publicado: (2017)

Impact of temperature and humidity on performance of the fecal immunochemical test for advanced colorectal neoplasia
por: Park, Chan Hyuk, et al.
Publicado: (2019)

Accuracy of a fecal immunochemical test according to outside temperature and travel time
por: Niedermaier, Tobias, et al.
Publicado: (2018)

Performance of the Fecal Immunochemical Test in Patients With a Family History of Colorectal Cancer
por: Moosavi, Sarvee, et al.
Publicado: (2019)

Effects of antithrombotic drugs on the results of fecal immunochemical test in colorectal neoplasms screening
por: Ibuka, Takashi, et al.
Publicado: (2021)

Positive fecal immunochemical test results are associated with non-colorectal cancer mortality
por: Jung, Yoon Suk, et al.
Publicado: (2022)

The Accuracy of Fecal Immunochemical Test in Colorectal Cancer Screening: A Meta-Analysis
por: Phuangrach, Nittaya, et al.
Publicado: (2022)

Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round
por: Stegeman, Inge, et al.
Publicado: (2012)

The Impact of Transitioning From Guaiac-Fecal Occult Blood Testing to Fecal Immunochemical Testing in a Canadian Colon Cancer Screening Program
por: Sultanian, Richard, et al.
Publicado: (2020)

Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option
por: Flitcroft, Kathy L, et al.
Publicado: (2012)

Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase
por: Caviglia, Gian Paolo, et al.
Publicado: (2016)

Fecal DNA Testing of TWIST1 Methylation Identifies Patients With Advanced Colorectal Adenoma Missed by Fecal Immunochemical Test for Hemoglobin
por: Suehiro, Yutaka, et al.
Publicado: (2020)

Detection of Colorectal Serrated Polyps by Stool DNA Testing: Comparison with Fecal Immunochemical Testing for Occult Blood (FIT)
por: Heigh, Russell I., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_020atbq3dg7p960t2esmqmo17t